Medicines and Healthcare products Regulatory Agency: Redundancy

(asked on 15th October 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had on potential redundancies with executive officers at the Medicines and Healthcare Products Regulatory Agency.


Answered by
Edward Argar Portrait
Edward Argar
Minister of State (Ministry of Justice)
This question was answered on 21st October 2021

The Department regularly meets with officials at the Medicines and Healthcare products Regulatory Agency (MHRA) to discuss a range of issues, including its transformation plans.

The Department has not made a specific assessment of the potential effect of redundancies at the MHRA. The MHRA continues to involve trades unions and employees through formal consultation as well as continuing opportunities for engagement with senior leaders.

Reticulating Splines